{
    "code": "02020574",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020574",
    "time": "2015-08-23 11:12:06",
    "許可證字號": "衛署藥輸字第020574號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/04\/06",
    "註銷理由": "自請註銷",
    "有效日期": "98\/08\/02",
    "發證日期": "83\/08\/02",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202057402",
    "中文品名": "雙鹽酸布克利汀",
    "英文品名": "BUCLIZINE DIHYDROCHLORIDE",
    "適應症": "抗組織胺劑。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "主成分略述": "BUCLIZINE 2HCL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1706301100  優喜碧股份有限公司",
    "申請商地址": "台北巿松山區光復北路１１巷３５號１２樓",
    "主製造廠": {
        "製造廠名稱": "F050024000  UCB.S.A. PHARMACEUTICAL SECTOR",
        "製造廠廠址": "CHEMIN DU FORIEST, 1420 BRAINE-L, ALLEUD, BELGIUMALLEE DE LA RECHERCHE,60 B-1070 BRUSSELS,BELGIUM",
        "製造廠公司地址": "ALLEE DE LA RECHERCHE,60 B-1070 BRUSSELS,BELGIUM",
        "製造廠國別": "BELGIUM",
        "製程": ""
    },
    "CCC號列": "29335990900 其他之結構中含嘧啶環（不論是否氫化）或六氫？？環之化合物Other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5622000110",
            "成分名稱": "BUCLIZINE 2HCL",
            "含量描述": "99.0-100.5",
            "含量": "",
            "單位": "%"
        }
    ]
}